These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis. Kreuz W; Martinez-Saguer I; Aygören-Pürsün E; Rusicke E; Heller C; Klingebiel T Transfusion; 2009 Sep; 49(9):1987-95. PubMed ID: 19497056 [TBL] [Abstract][Full Text] [Related]
25. Clinical presentation, pathophysiology, diagnosis, and treatment of acquired and hereditary angioedema: Exploring state-of-the-art therapies in RI. Guo C; Settipane RA R I Med J (2013); 2016 Jun; 99(6):41-4. PubMed ID: 27247973 [TBL] [Abstract][Full Text] [Related]
28. Hereditary angiodema: a current state-of-the-art review, VI: novel therapies for hereditary angioedema. Frank MM Ann Allergy Asthma Immunol; 2008 Jan; 100(1 Suppl 2):S23-9. PubMed ID: 18220149 [TBL] [Abstract][Full Text] [Related]
29. The importance of recognizing and managing a rare form of angioedema: hereditary angioedema due to C1-inhibitor deficiency. Jacobs J; Neeno T Postgrad Med; 2021 Aug; 133(6):639-650. PubMed ID: 33993830 [TBL] [Abstract][Full Text] [Related]
30. Hereditary Angioedema with Normal C1 Inhibitor: Update on Evaluation and Treatment. Magerl M; Germenis AE; Maas C; Maurer M Immunol Allergy Clin North Am; 2017 Aug; 37(3):571-584. PubMed ID: 28687110 [TBL] [Abstract][Full Text] [Related]
31. [Allergy-immunology. New therapies for acute attacks in hereditary angioedema]. Leimgruber A Rev Med Suisse; 2011 Jan; 7(278):103-5. PubMed ID: 21400938 [TBL] [Abstract][Full Text] [Related]
32. An update on hereditary angioedema. Hsu D; Shaker M Curr Opin Pediatr; 2012 Oct; 24(5):638-46. PubMed ID: 22935756 [TBL] [Abstract][Full Text] [Related]
33. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway. Kaplan AP; Joseph K Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213 [TBL] [Abstract][Full Text] [Related]
34. Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis. Joseph K; Tholanikunnel TE; Kaplan AP Ann Allergy Asthma Immunol; 2010 Jan; 104(1):50-4. PubMed ID: 20143645 [TBL] [Abstract][Full Text] [Related]
38. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema. Bork K Immunotherapy; 2014; 6(5):533-51. PubMed ID: 24635050 [TBL] [Abstract][Full Text] [Related]
39. New treatment options for acute edema attacks caused by hereditary angioedema. Thomas MC; Shah S Am J Health Syst Pharm; 2011 Nov; 68(22):2129-38. PubMed ID: 22058099 [TBL] [Abstract][Full Text] [Related]
40. Hereditary angioedema: new hopes for an orphan disease. Reshef A; Leibovich I; Goren A Isr Med Assoc J; 2008 Dec; 10(12):850-5. PubMed ID: 19160940 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]